Study Of The Safety And Efficacy Of Lyrica In The Treatment Of Newly Diagnosed Partial Epilepsy
Clinical trial NCT00280059 · COMPLETED
Trial details
- NCT number
- NCT00280059
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-08-01
- Primary completion
- 2009-12-01
- Enrollment
- 660
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.